p75 Neurotrophin Receptor Cleavage by α- and γ-Secretases Is Required for Neurotrophin-mediated Proliferation of Brain Tumor-initiating Cells
Peter Forsyth(Moffitt Cancer Center), Rajappa S. Kenchappa(Mayo Clinic in Florida), Geoffrey T. Gibney(Georgetown University), Prakash Chinnaiyan(Moffitt Cancer Center), Niveditha Krishna(Center for Neuro-Oncology), J. Gerardo Valadez(Vanderbilt University), David Fenstermacher(University of South Florida), Michael K. Cooper(Vanderbilt University Medical Center), Bruce Carter(Allen Institute for Brain Science), Lisa Potthast(University of South Florida), Philip Barker(University of British Columbia), Michelle Fournier(Moffitt Cancer Center), Michele Zeinieh(McGill University Health Centre), Xiaotao Qu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Samuel O. Lawn(University of Calgary)
Cited by 66
Related Papers
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
|The Lancet Oncology|2017|1.8k
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
|Journal of Clinical Oncology|2020|1.3k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
|PLoS ONE|2015|906
Abbreviated Course of Radiation Therapy in Older Patients With Glioblastoma Multiforme: A Prospective Randomized Clinical Trial
|Journal of Clinical Oncology|2004|888